Breast cancer epidemiology according to recognized breast cancer risk factors in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial Cohort

被引:92
|
作者
Lacey, James V., Jr. [1 ]
Kreimer, Aimee R. [2 ,3 ]
Buys, Saundra S. [4 ]
Marcus, Pamela M. [5 ]
Chang, Shih-Chen [6 ,7 ]
Leitzmann, Michael F. [7 ,8 ]
Hoover, Robert N. [9 ]
Prorok, Philip C. [5 ]
Berg, Christine D. [2 ]
Hartge, Patricia [9 ]
机构
[1] NCI, Hormonal & Reprod Epidemiol Branch, Div Canc Epidemiol & Genet, NIH, Rockville, MD USA
[2] NIH, Early Detect Res Grp, Canc Prevent Div, Rockville, MD USA
[3] NCI, Infect & Immunoepidemiol Branch, Div Canc Epidemiol & Genet, NIH, Rockville, MD USA
[4] Univ Utah, Dept Internal Med, Huntsman Canc Inst, Hlth Sci Ctr, Salt Lake City, UT 84112 USA
[5] NCI, Biometry Res Grp, Canc Prevent Div, NIH, Rockville, MD USA
[6] AstraZeneca, Global Epidemiol Dept, Wilmington, DE USA
[7] NCI, Nutr Epidemiol Branch, Div Canc Epidemiol & Genet, NIH, Rockville, MD USA
[8] Univ Regensburg, Inst Epidemiol & Prevent Med, Regensburg, Germany
[9] NCI, Epidemiol & Biostat Program, Div Canc Epidemiol & Genet, NIH, Rockville, MD USA
关键词
AGE; WOMEN; MENOPAUSE; GENOME; BIRTH; ASSOCIATION; MENARCHE; GENES; MODEL; FAT;
D O I
10.1186/1471-2407-9-84
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Multidisciplinary attempts to understand the etiology of breast cancer are expanding to increasingly include new potential markers of disease risk. Those efforts may have maximal scientific and practical influence if new findings are placed in context of the well-understood lifestyle and reproductive risk factors or existing risk prediction models for breast cancer. We therefore evaluated known risk factors for breast cancer in a cancer screening trial that does not have breast cancer as a study endpoint but is large enough to provide numerous analytic opportunities for breast cancer. Methods: We evaluated risk factors for breast cancer (N = 2085) among 70,575 women who were randomized in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. Using Poisson regression, we calculated adjusted relative risks [RRs, with 95% confidence intervals (CIs)] for lifestyle and reproductive factors during an average of 5 years of follow-up from date of randomization. Results: As expected, increasing age, nulliparity, positive family history of breast cancer, and use of menopausal hormone therapy were positively associated with breast cancer. Later age at menarche (16 years or older vs. < 12: RR = 0.81, 95% CI, 0.65-1.02) or menopause (55 years or older vs. < 45: RR = 1.29, 95% CI, 1.03-1.62) were less strongly associated with breast cancer than was expected. There were weak positive associations between taller height and heavier weight, and only severe obesity [ body mass index (BMI; kg/m(2)) 35 or more vs. 18.5-24.9: RR = 1.21, 95% CI, 1.02-1.43] was statistically significantly associated with breast cancer. Conclusion: The ongoing PLCO trial offers continued opportunities for new breast cancer investigations, but these analyses suggest that the associations between breast cancer and age at menarche, age at menopause, and obesity might be changing as the underlying demographics of these factors change.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Breast cancer epidemiology according to recognized breast cancer risk factors in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial Cohort
    James V Lacey
    Aimee R Kreimer
    Saundra S Buys
    Pamela M Marcus
    Shih-Chen Chang
    Michael F Leitzmann
    Robert N Hoover
    Philip C Prorok
    Christine D Berg
    Patricia Hartge
    [J]. BMC Cancer, 9
  • [2] Alcohol, genetics and risk of breast cancer in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial
    Catherine A. McCarty
    Douglas J. Reding
    John Commins
    Craig Williams
    Meredith Yeager
    James K. Burmester
    Catherine Schairer
    Regina G. Ziegler
    [J]. Breast Cancer Research and Treatment, 2012, 133 : 785 - 792
  • [3] Alcohol, genetics and risk of breast cancer in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial
    McCarty, Catherine A.
    Reding, Douglas J.
    Commins, John
    Williams, Craig
    Yeager, Meredith
    Burmester, James K.
    Schairer, Catherine
    Ziegler, Regina G.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2012, 133 (02) : 785 - 792
  • [4] Energy Intake and Risk of Postmenopausal Breast Cancer: An Expanded Analysis in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO) Cohort
    Sue, Laura Y.
    Schairer, Catherine
    Ma, Xiaomei
    Williams, Craig
    Chang, Shih-Chen
    Millers, Anthony B.
    McCarty, Catherine A.
    Willcox, Bradley J.
    Ziegler, Regina G.
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2009, 18 (11) : 2842 - 2850
  • [5] Prediagnostic White Blood Cell DNA Methylation and Risk of Breast Cancer in the Prostate Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO) Cohort
    Sturgeon, Susan R.
    Sela, David A.
    Browne, Eva P.
    Einson, Jonah
    Rani, Asha
    Halabi, Mohamed
    Kania, Thomas
    Keezer, Andrew
    Balasubramanian, Raji
    Ziegler, Regina G.
    Schairer, Catherine
    Kelsey, Karl T.
    Arcaro, Kathleen F.
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2021, 30 (08) : 1575 - 1581
  • [6] White blood cell DNA methylation and risk of breast cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO)
    Sturgeon, Susan R.
    Pilsner, J. Richard
    Arcaro, Kathleen F.
    Ikuma, Kaoru
    Wu, Haotian
    Kim, Soon-Mi
    Chopra-Tandon, Nayha
    Karpf, Adam R.
    Ziegler, Regina G.
    Schairer, Catherine
    Balasubramanian, Raji
    Reckhow, David A.
    [J]. BREAST CANCER RESEARCH, 2017, 19
  • [7] White blood cell DNA methylation and risk of breast cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO)
    Susan R. Sturgeon
    J. Richard Pilsner
    Kathleen F. Arcaro
    Kaoru Ikuma
    Haotian Wu
    Soon-Mi Kim
    Nayha Chopra-Tandon
    Adam R. Karpf
    Regina G. Ziegler
    Catherine Schairer
    Raji Balasubramanian
    David A. Reckhow
    [J]. Breast Cancer Research, 19
  • [8] Lung Cancer Screening in the Randomized Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial
    Hocking, William G.
    Hu, Ping
    Oken, Martin M.
    Winslow, Stephen D.
    Kvale, Paul A.
    Prorok, Philip C.
    Ragard, Lawrence R.
    Commins, John
    Lynch, David A.
    Andriole, Gerald L.
    Buys, Saundra S.
    Fouad, Mona N.
    Fuhrman, Carl R.
    Isaacs, Claudine
    Yokochi, Lance A.
    Riley, Thomas L.
    Pinsky, Paul F.
    Gohagan, John K.
    Berg, Christine D.
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2010, 102 (10) : 722 - 731
  • [9] Dietary folate intake, alcohol use and postmenopausal breast cancer risk in the Prostate, Lung, Colorectal, Ovarian (PLCO) Cancer Screening Trial
    Stolzenberg-Solomon, RZ
    Leitzman, M
    Chang, SS
    Johnson, K
    Johnson, C
    Buys, S
    Hoover, R
    Zeigler, R
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2004, 159 (11) : S69 - S69
  • [10] Vitamin K intake and prostate cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer (PLCO) Screening Trial
    Hoyt, Margaret
    Reger, Michael
    Marley, Andrew
    Fan, Hao
    Liu, Ziyue
    Zhang, Jianjun
    [J]. AMERICAN JOURNAL OF CLINICAL NUTRITION, 2019, 109 (02): : 392 - 401